Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Heronova Pharmaceuticals

Clinical trials sponsored by Heronova Pharmaceuticals, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug for rare eye disease begins first human tests Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug for rare eye disease begins first human tests

Knowledge-focused Recruiting now

This early-phase trial tests the safety of an oral drug called DC6001 in 76 healthy adults. Researchers will give single or multiple doses to see how the body handles the drug and if it causes side effects. This study does not involve people with Stargardt disease and is not desi…

Phase 1 • Sponsor: Heronova Pharmaceuticals • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:06 UTC